These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27815000)

  • 1. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
    Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
    Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
    [No Abstract]   [Full Text] [Related]  

  • 2. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
    Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.
    Xu L; Zhou X; Peppelenbosch MP; Pan Q
    Arch Virol; 2015 Feb; 160(2):435-9. PubMed ID: 25476751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.
    Wu X; Dao Thi VL; Liu P; Takacs CN; Xiang K; Andrus L; Gouttenoire J; Moradpour D; Rice CM
    Gastroenterology; 2018 Feb; 154(3):663-674.e7. PubMed ID: 29277559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients.
    Kahveci AS; Tahan V
    Turk J Gastroenterol; 2016 Mar; 27(2):205-6. PubMed ID: 27015627
    [No Abstract]   [Full Text] [Related]  

  • 7. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?
    Brochot E; Bodeau S; Duverlie G
    Ther Drug Monit; 2015 Aug; 37(4):550-1. PubMed ID: 25525764
    [No Abstract]   [Full Text] [Related]  

  • 9. Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection.
    van der Valk M; Zaaijer HL; Kater AP; Schinkel J
    J Hepatol; 2017 Jan; 66(1):242-243. PubMed ID: 27702641
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of sofosbuvir and NITD008 in extrahepatic neuronal cells against HEV.
    Jagst M; Gömer A; Todt D; Steinmann E
    Antiviral Res; 2024 Jul; 227():105922. PubMed ID: 38825018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
    Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
    J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study.
    Cornberg M; Pischke S; Müller T; Behrendt P; Piecha F; Benckert J; Todt D; Steinmann E; Papkalla A; von Karpowitz M; Koch A; Lohse A; Hardtke S; Manns MP; Wedemeyer H
    J Hepatol; 2020 Sep; 73(3):696-699. PubMed ID: 32624195
    [No Abstract]   [Full Text] [Related]  

  • 15. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
    Kaushik N; Anang S; Ganti KP; Surjit M
    DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus.
    Gallego I; Sheldon J; Moreno E; Gregori J; Quer J; Esteban JI; Rice CM; Domingo E; Perales C
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3786-93. PubMed ID: 27067341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Wang Y; Chen G; Pan Q; Zhao J
    Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell lines.
    Ali L; Idrees M; Ali M; Hussain A; Ur Rehman I; Ali A; Iqbal SA; Kamel EH
    BMC Res Notes; 2014 Apr; 7():247. PubMed ID: 24742271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection.
    Sundaram V; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):13-20. PubMed ID: 26560449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.